Multifactorial trial in the prevention of coronary heart disease: 3. Incidence and mortality results. 1983


Incidence and mortality results are presented from an international controlled trial of multifactorial prevention of coronary heart disease, involving randomization of 66 factories (49 781 men) in U.K., Belgium, Italy and Poland (Cracow). Results for Poland (Warsaw) are not yet complete. Net average reductions in risk factors (all subjects) were 1.2% for plasma cholesterol, 8.9% for daily cigarettes, 0.4% for weight, 2.0% for systolic blood pressure, and 11.1% for a combined risk estimate. Greater reductions occurred in high-risk subjects (19.4% for the combined estimate). The net overall reduction in CHD rates was 7.4% (95% confidence interval -29 to +15%) for deaths (722 cases), and 3.9% (95% confidence interval -10 to +2%) for fatal CHD + non-fatal myocardial infarction (1502 cases). Among men aged 40-49 the reduction for this end-point was 15%; at ages 50-59 there was a small net increase. All-causes deaths after an early adverse trend showed 2.7% reduction overall. There were large differences between centres, ranging from a 5% net increase in CHD for U.K. to a decrease of 24% in Belgium. In Belgium the decrease both in CHD and in all deaths was significant at the 5% level. The effect on CHD in the different centres correlated broadly with their changes in risk factors. It is concluded that reduction in major coronary risk factors in industrial populations is possible, but it depends on adequate resources; the results support the hypotheses that CHD risk in middle-aged men is reversible and that community intervention can be beneficial.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

No sufficiently related or similar publications found.

Copied contents to your clipboard!